Predictive Technology Gross Margin 2017-2021 | PRED
Current and historical gross margin for Predictive Technology (PRED) over the last 10 years. The current gross profit margin for Predictive Technology as of March 31, 2021 is %.
| Predictive Technology Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2021-03-31 | $0.02B | $0.01B | 36.84% |
| 2020-12-31 | $0.02B | $0.00B | 22.22% |
| 2020-09-30 | $0.02B | $0.00B | 19.05% |
| 2020-06-30 | $0.02B | $0.00B | 12.50% |
| 2020-03-31 | $0.03B | $0.01B | 32.35% |
| 2019-12-31 | $0.04B | $0.02B | 43.59% |
| 2019-09-30 | $0.04B | $0.02B | 55.81% |
| 2019-06-30 | $0.04B | $0.03B | 65.12% |
| 2019-03-31 | $0.04B | $0.03B | 72.97% |
| 2018-12-31 | $0.03B | $0.02B | 73.33% |
| 2018-09-30 | $0.02B | $0.02B | 72.73% |
| 2018-06-30 | $0.02B | $0.01B | 75.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Predictive Technology Group, Inc. is a therapeutics and life sciences company, in the use of data analytics for disease identification and subsequent therapeutic intervention through unique novel gene-based diagnostics, biotechnology treatments and companion therapeutics. The company through its' wholly-owned subsidiaries Predictive Therapeutics and Predictive Biotech focuses on clinical categories consists of Endometriosis, Scoliosis, Degenerative Disc Disease and Regenerative Human Cell and Tissue Products. Predictive Biotech efforts to advance regenerative medicine and Predictive Therapeutics is committed to assisting women in overcoming the devastating consequences of endometriosis via appropriate early-stage diagnosis and subsequent treatment. Predictive Technology Group, Inc. is based in Salt Lake City, UT. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.573B | 22.01 |
| Inspire Medical Systems (INSP) | United States | $7.095B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.623B | 0.00 |
| Axonics (AXNX) | United States | $3.399B | 0.00 |
| 10x Genomics (TXG) | United States | $3.279B | 0.00 |
| Enovis (ENOV) | United States | $3.080B | 23.40 |
| Azenta (AZTA) | United States | $2.905B | 236.77 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.789B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.644B | 0.00 |
| Privia Health (PRVA) | United States | $2.156B | 95.63 |
| Schrodinger (SDGR) | United States | $1.738B | 0.00 |
| Omnicell (OMCL) | United States | $1.260B | 30.82 |
| Phreesia (PHR) | United States | $1.237B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.854B | 0.00 |
| Standard BioTools (LAB) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.330B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.322B | 0.00 |
| Pulmonx (LUNG) | United States | $0.290B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.158B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.158B | 0.00 |
| American Well (AMWL) | United States | $0.154B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.147B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.132B | 0.00 |
| TruBridge (TBRG) | United States | $0.116B | 4.95 |
| 111 (YI) | China | $0.088B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.079B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Movano (MOVE) | United States | $0.027B | 0.00 |
| Cue Health (HLTH) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.020B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Centogene (CNTG) | Germany | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |